Natural Terpenoids from Ambrosia Species Are Active In Vitro and In Vivo against Human Pathogenic Trypanosomatids

PLoS Neglected Tropical Diseases

Volumn 7, Issue 10, 2013, Pages

  Sülsen, Valeria P ^a   Cazorla, Silvia I ^a   Frank, Fernanda M ^a   Laurella, Laura C ^a   Muschietti, Liliana V ^a   Catalán, Cesar A ^b   Martino, Virginia S ^a   Malchiodi, Emilio L ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; CORDILIN; CUMANIN; DAUCOSTEROL; PSILOSTACHYIN; TERPENOID; UNCLASSIFIED DRUG;

AMBROSIA ELATIOR; AMBROSIA SCABRA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY TEST; EPIMASTIGOTE; IC 50; KINETOPLASTIDA; LEISHMANIASIS; MALE; MOUSE; NONHUMAN; RAGWEED; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

AMBROSIA; ANIMALS; ANTIPROTOZOAL AGENTS; CELL SURVIVAL; DRUG INTERACTIONS; INHIBITORY CONCENTRATION 50; LEISHMANIA; MALE; MICE; MICE, INBRED C3H; PARASITEMIA; TERPENES; TRYPANOSOMA CRUZI;

EID: 84887273049     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002494     Document Type: Article

References (42)

1. Demain A, Zhang L (2005) Natural products and drug discovery. In: Zhang L, Demain A, editors. Natural Products. Drug Discovery and Therapeutic Medicine. New Jersey: Humana Press. pp. 3-29.
2. World Health Organization (2010) First WHO report on neglected tropical diseases. Available: http://www.who.int/neglected_diseases/2010report/en/. Accessed in December 2012.
3. World Health Organization (2012) Chagas disease (American trypanosomiasis). Fact sheet pp. 340 Available: http://www.who.int/mediacentre/factsheets/fs340/en/index.html. Accessed in December 2012.
4. Drugs for Neglected Diseases Initiative (2010) Argentina: more action needed. Newsletter 19: 5.
5. World Health Organization (2010) Control of the Leishmaniases. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22-26 March 2010. WHO Tech Rep Ser 949: 1-186.
6. Frank FM, Fernandez MM, Taranto NJ, Cajal SP, Margni RA, et al. (2003) Characterization of human infection by Leishmania spp. in the Northwest of Argentina: immune response, double infection with Trypanosoma cruzi and species of Leishmania involved. Parasitology 126: 31-39.
7. Salomón OD, Acardi SA, Liotta DJ, Fernández MS, Lestanic E, et al. (2009) Epidemiological aspects of cutaneous leishmaniasis in the Iguazú falls area of Argentina. Acta Trop 109: 5-11.
8. Urbina JA, (2010) Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop 115: 55-68.
9. Drugs for Neglected Diseases Initiative. Leishmaniasis. Current treatments. Available: http://www.dndi.org/diseases-projects/diseases/vl/current-treatment.html. Accessed in April 2013.
10. Maimone TJ, Baran PS, (2007) Modern synthesis efforts toward biologically active terpenes. Nat Chem Biol 3: 396-407.
11. Wang G, Tang W, Bidigare R (2005) Terpenoids as therapeutic drugs and pharmaceutical agents. In: Zhang L, Demain A, editors. Natural Products. Drug Discovery and Therapeutic Medicine. New Jersey: Humana Press. pp. 197-227.
12. Ramírez-Macías I, Marín C, Chahboun R, Messouri I, Olmo F, et al. (2012) In vitro and in vivo studies of the trypanocidal activity of four terpenoid derivatives against Trypanosoma cruzi. Am J Trop Med Hyg 87: 481-488.
13. Ganfon H, Bero J, Tchinda AT, Gbaguidi F, Gbenou J, et al. (2012) Antiparasitic activities of two sesquiterpenic lactones isolated from Acanthospermum hispidum D.C. J Ethnopharmacol 141: 411-417.
14. Izumi E, Ueda-Nakamura T, Veiga VF Jr, Pinto AC, Nakamura CV, (2012) Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity. J Med Chem 55: 2994-3001.
15. Odonne G, Herbette G, Eparvier V, Bourdy G, Rojas R, et al. (2011) Antileishmanial sesquiterpene lactones from Pseudelephantopus spicatus, a traditional remedy from the Chayahuita Amerindians (Peru) Part III. J Ethnopharmacol 137: 875-879.
16. Polonio T, Efferth T, (2008) Leishmaniasis: drug resistance and natural products. Int J Mol Med 22: 277-286.
17. Izumi E, Ueda-Nakamura T, Dias Filho BP, Veiga Junior VF, Nakamura CV, (2011) Natural products and Chagas disease: a review of plant compounds studied for activity against Trypanosoma cruzi. Nat Prod Rep 28: 809-823.
18. Schmidt TJ, Khalid SA, Romanha AJ, Alves TM, Biavatti MW, et al. (2012) The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases- part I. Curr Med Chem 19: 2128-2175.
19. Setzer W, Setzer M (2006) Antitrypanosomal agents from higher plants. In: Williams L, editor. Biologically Active Natural Products for the 21st Century. Kerala: Research Signpost. pp. 47-95.
20. Sülsen VP, Frank FM, Cazorla SI, Anesini CA, Malchiodi EL, et al. (2008) Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae). Antimicrob Agents Chemother 52: 2415-2419.
21. Sülsen VP, Barrera P, Muschietti L, Martino V, Sosa M, (2010) Antiproliferative effect and ultrastructural alterations induced by psilostachyin on Trypanosoma cruzi. Molecules 15: 515 545-553.
22. Sülsen VP, Frank FM, Cazorla SI, Barrera P, Freixa B, et al. (2011) Psilostachyin C: a natural compound with trypanocidal activity. Int J Antimicrob Agents 37: 536-543.
23. Sülsen V, Gutierrez Yappu D, Laurella L, Anesini C, Gimenez Turba A, et al. (2011) In vitro antiplasmodial activity of sesquiterpene lactones from Ambrosia tenuifolia. Evid Based Complement Alternat Med 2011: 352938.
24. Alba Soto CD, Mirkin GA, Solana ME, González Cappa SM, (2003) Trypanosoma cruzi infection modulates in vivo expression of major histocompatibility complex class II molecules on antigen-presenting cells and T-cell stimulatory activity of dendritic cells in a strain-dependent manner. Infect Immun 71: 1194-1199.
25. National Research Council (2011) Guide for the care and use of laboratory animals. Eighth Edition.Washington DC: National Academy Press.
26. Buckner FS, Verlinde CL, La Flamme AA, Van Voorhis WC, (1996) Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing β- galactosidase. Antimicrob Agents Chemother 40: 2592-2597.
27. Ciccarelli AB, Frank FM, Puente V, Malchiodi EL, Batlle A, et al. (2012) Antiparasitic effect of vitamin B12 on Trypanosoma cruzi. Antimicrob Agents Chemother 56: 5315-5320.
28. Porter T, Mabry T, (1969) Sesquiterpene lactones. Constituents of Ambrosia artemisiifolia L. (Compositae). Phytochemistry 8: 793-794.
29. Romo J, Joseph-Nathan P, Siade G, (1966) The structure of cumanin, a constituent of Ambrosia cumanensis. Tetrahedron 22: 1499-1506.
30. Zingales B, Miles MA, Campbell DA, Tibayrenc M, Macedo AM, et al. (2012) The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications. Infect Genet Evol 12: 240-253.
31. Risso MG, Garbarino GB, Mocetti E, Campetella O, Gonzalez Cappa SM, et al. (2004) Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages. J Infect Dis 189 (12) (): 2250-2259.
32. Canavaci AM, Bustamante JM, Padilla AM, Perez Brandan CM, Simpson LJ, et al. (2010) In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds. PLoS Negl Trop Dis 4: e740.
33. Drugs for Neglected Diseases Initiative (DNDi). Available: http://www.dndi.org/. Accessed in June 2013.
34. Malchiodi EL, Chiaramonte MG, Taranto NJ, Zwirner NW, Margni RA, (1994) Cross reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp: use of immunoblotting and ELISA with a purified antigen (Ag 163B6). Clin Exp Immunol 97: 417-423.
35. Chiaramonte MG, Zwirner NW, Caropresi SL, Taranto NJ, Malchiodi EL, (1996) Trypanosoma cruzi and Leishmania spp. human mixed infection. Am J Trop Med Hyg 54: 271-273.
36. Chiaramonte MG, Frank FM, Furer GM, Taranto NJ, Margni RA, et al. (1999) Polymerase chain reaction reveals T. cruzi infection suspected by serology in cutaneous and mucocutaneous leishmaniasis patients. Acta Trop 72: 295-308.
37. Aponte JC, Yang H, Vaisberg AJ, Castillo D, Malaga E, et al. (2010) Cytotoxic and anti infective sesquiterpenes present in Plagiochila disticha (Plagiochilaceae) and Ambrosia peruviana (Asteraceae). Planta Med 76: 705-707.
38. Schmidt TJ, Brun R, Willuhn G, Khalid SA, (2002) Anti-trypanosomal activity of helenalin and some structurally related sesquiterpene lactones. Planta Med 68: 750-751.
39. Lastra AL, Ramírez TO, Salazar L, Martínez M, Trujillo-Ferrara J, (2004) The ambrosanolide cumanin inhibits macrophage nitric oxide synthesis: some structural considerations. J Ethnopharmacol 95: 221-227.
40. Lozano E, Barrera P, Salinas R, Vega I, Nieto M, et al. (2012) Sesquiterpene lactones and the diterpene 5-epi-icetexone affect the intracellular and extracellular stages of Trypanosoma cruzi. Parasitol Int 61: 628-633.
41. Tiuman TS, Ueda-Nakamura T, García Cortez DA, Dias Filho BP, Morgado-Díaz JA, et al. (2005) Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium. Antimicrob Agents Chemother 49: 176-182.
42. Izumi E, Morello LG, Ueda-Nakamura T, Yamada-Ogatta SF, Filho BP, et al. (2008) Trypanosoma cruzi: antiprotozoal activity of parthenolide obtained from Tanacetum parthenium (L.) Schultz Bip. (Asteraceae, Compositae) against epimastigote and amastigote forms. Exp Parasitol 118: 324-330.